Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Continuing Access to Harvard Longitudinal Survey Data

Active
FDA_7222026Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Health And Human Services → Food And Drug AdministrationView Agency

NAICS

N/A

Place of Performance

Rockville, MD, 20852, USA

Set-Aside

8A

Documents

(2)

Scope+of+Work.pdf

PDF

INTENT+TO+SOLE+SOURCE.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Food And Drug Administration
Contacts1 person available
OfficeRockville, MD, 20841, US
Organization / Agency
Department Of Health And Human Services → Food And Drug Administration
View Agency Profile
Office AddressRockville, MD, 20841, US
Contacts

Full Description

Show more

Cross-sectional data sets, such as derived from the National Health and Nutritional Examination Survey (NHANES), are readily available at no cost over the web, and analyses of such data sets can help suggest potential associations between dietary intake exposures and health outcomes. However, because cross- sectional surveys collect exposure and outcome data at the very same point in time, they cannot help us understand if exposures through routine dietary intake and other exposures related to regulated products preceded diagnosis of adverse health conditions.



Longitudinal data – often collected repeatedly from participants in prospective cohort studies conducted over several years – help to reveal relationships between dietary and environmental exposures and the development of health conditions over time. The FDA Human Foods Program (HFP)/Office of Surveillance Strategy and Risk Prioritization (OSSRP)/Division of Evaluation and Population Health Science (DEPHS)/Epidemiology and Medical Sciences Branch (EMSB) is interested in obtaining such longitudinal data from the ongoing President and Fellows of Harvard College/Harvard School of Public Health (HSPH) longitudinal studies:


  • Nurses’ Health Study original cohort (NHS: ~122,000 participants, since 1976)
  • Nurses’ Health Study II (NHSII: ~116,000 participants, began in 1989)
  • Health Professionals Follow-Up Study (HPFS: ~100,000 men, since 1986)
  • Growing Up Today Study (GUTS: children of NHS participants, including 16,882 girls and boys; since 1996)
  • Growing Up Today Study 2 (GUTS2: children of NHSII participants, including 10,923 girls and boys; since 2004)

Analyses of longitudinal data from these studies will help monitor diet and lifestyle risk factors, allow for scientific evaluation of potential causal links between these factors and chronic disease incidence, and enhance understanding of individual and intergenerational relationships between dietary intake, lifestyle exposures, and chronic conditions/long-term health effects throughout the lifespan, among parents and offspring, including evaluating grandmother-maternal-child outcomes. This information will help the FDA improve dietary policy and consumer education to protect and promote public health.
Please see attched SOW.

More opportunities from Department Of Health And Human Services → Food And Drug Administration

Same awarding agency

NAICS: 334516
New
Federal
Three (3) Rigaku Icon-X Handheld 1064nm Raman Spectrometers - Brand NameThe U.S. Food and Drug Administration’s National Forensic Chemistry Center in Cincinnati, Ohio, is soliciting quotations for three Rigaku IconX handheld 1064nm Raman spectrometers under solicitation number OC-OCS-26-C-4920, issued as a Request for Quotations under FAR Part 13 Simplified Acquisition Procedures. This is a brand-name requirement with no “or equal” alternatives permitted, and only the original equipment manufacturer or currently authorized dealers/resellers of Rigaku Analytical Devices may submit quotations, with proof of authorization required for non-OEM respondents. Each system must include all standard features, accessories, CommandSuite software, and three years of manufacturer’s warranty, with delivery F.O.B. destination to Cincinnati, Ohio, no later than 90 days after award. The acquisition is unrestricted, with the NAICS code 334516 and PSC 6640 applying, and all quotations must be submitted via email to james.jenretteiii@fda.hhs.gov by 12:00 PM Eastern Time on July 29, 2026, with a subject line format specifying the company name. Quoters must maintain an active SAM.gov registration at the time of submission and award. Questions regarding the RFQ must be submitted in writing by 12:00 PM Eastern Time on July 24, 2026, and award will be made to the lowest-priced, technically acceptable quotation. The solicitation document serves as the complete and only solicitation, incorporating all applicable provisions and clauses from the most current Federal Acquisition Circular. The point of contact for inquiries is James Jenrette, and the office responsible for issuing the RFQ is located in Rockville, Maryland, though the instruments are required to be delivered to Cincinnati, Ohio. This procurement utilizes firm-fixed-price purchase order terms and will be evaluated solely on price and technical acceptability without negotiation.
Analytical Laboratory Instrument Manufacturing

POSTED

3 days ago

DEADLINE

in 6 days
View Details
NAICS: 334516
New
Federal
Maxwell RSC 48 DNA Extraction Systems or Equal – Commercial Blanket Purchase Agreement (BPA)The U.S. Food and Drug Administration is soliciting quotations under Solicitation Number HFP-2026-133524 for the acquisition of Maxwell RSC 48 DNA Extraction Systems or equivalent alternatives, along with associated services including installation, on-site training, and one-year warranty support for laboratory facilities across multiple states. This is a full and open competition not set aside for small businesses, conducted under FAR Part 12 streamlined procedures for commercial products, with awards made using the Lowest Price Technically Acceptable source selection process. Offerors must meet or exceed all technical specifications outlined in the solicitation, with equal products requiring comprehensive documentation to prove compliance. Delivery must be completed within 90 calendar days of order placement, followed by installation within 14 days, all subject to FOB destination terms and final acceptance after operational testing and training completion. Initial delivery locations include FDA labs in Arkansas, Georgia, California, Colorado, Washington, and New York. Quotations are due by July 31, 2026, at 10:00 a.m. Eastern Time and must be submitted electronically to the Contracting Officer. The acquisition incorporates standard FAR provisions and clauses for commercial products, alongside applicable HHSAR clauses governing installation, training, warranty, invoicing, and electronic payment requirements. Evaluation will assess technical acceptability, past performance, and price, with required attachments including a Performance Work Statement, Pricing Schedule, SF-18, Buy American Certificate, Past Performance Reference Form, Technical Compliance Matrix, and Subcontracting Plan template. Questions must be submitted by July 24, 2026, at 10:00 a.m. Eastern Time. The point of contact is Michele Jackson of the FDA’s Office of Acquisitions and Grants Services, based in Rockville, Maryland.
Analytical Laboratory Instrument Manufacturing

POSTED

3 days ago

DEADLINE

in 8 days
View Details
NAICS: 541511
Federal
Notice of Intent to Sole Source for FDA-iRISK® System for Food Safety Risk Assessment - Indefinite Delivery Indefinite Quantity (IDIQ)The Food and Drug Administration intends to sole source a three-year Indefinite Delivery Indefinite Quantity contract to Risk Sciences International for the ongoing management, technical support, enhancements, and operations and maintenance of the FDA-iRISK system, which includes both the public-facing FDA-iRISK 5.0 and the institutional FDA-iRISK 5.1i versions. This peer-reviewed food safety modeling tool enables users to evaluate and rank risks from microbial and chemical hazards, predict the effectiveness of control measures, and express outcomes in public health metrics, making it a critical asset for FDA regulatory and research activities as well as for external stakeholders in the scientific community. Risk Sciences International is identified as the sole provider capable of meeting the technical requirements due to its exclusive ownership and deep institutional knowledge of the FDA-iRISK system’s architecture and functionality. The procurement is being conducted under FAR 6.302-1 for other than full and open competition, with the NAICS code 541511 for custom computer programming services, and no solicitation document is available for competitive bids. The agency will consider any information submitted by other potential providers by 9:00 AM Eastern Time on July 24, 2026, at Natasha.Abbington@fda.hhs.gov, but an award to Risk Sciences International is expected approximately 15 days after the notice date unless another vendor demonstrates superior capability. This is not a request for proposals, and responses are being solicited solely to inform the government’s decision on whether to pursue competitive award, with final selection based on agency discretion and determinations of cost, technical merit, and program continuity.
Custom Computer Programming Services

POSTED

8 days ago

DEADLINE

in about 24 hours
View Details